Risk factors for hepatitis B virus reactivation after conformal radiotherapy in patients with hepatocellular carcinoma-Reference-Cited by-同舟云学术

Risk factors for hepatitis B virus reactivation after conformal radiotherapy in patients with hepatocellular carcinoma

Published:2014-04-20 Issue:6 Volume:105 Page:697-703
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Huang Wei¹,Zhang Wei²,Fan Min¹,Lu Yanda³,Zhang Jian¹,Li Hongsheng¹,Li Baosheng¹

Affiliation:

1. Department of Radiation Oncology VI Shandong Cancer Hospital Shandong Academy of Medical Sciences Shandong's Key Laboratory of Radiation Oncology JinanChina

2. Department of Radiation Oncology Yuhuangding Hospital YantaiChina

3. Cancer Center The Third People's Hospital of Jiujiang Jiujiang China

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.12400

Reference26 articles.

1. Clinical Scoring System to Predict Hepatocellular Carcinoma in Chronic Hepatitis B Carriers

2. Prevalence of hepatitis B in the southeast of China

3. Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: A prospective study of 626 patients with identification of risk factors

5. Steroid-free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV-carriers with lymphoma

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Time variation of high-risk groups for liver function deteriorations within fluctuating long-term liver function after hepatic radiotherapy in patients with hepatocellular carcinoma;European Journal of Medical Research;2024-02-07

2. Selection of HBV key reactivation factors based on maximum information coefficient combined with cosine similarity;Technology and Health Care;2023-06-29

3. Correlation of HBV DNA and Hepatitis B Surface Antigen Levels With Tumor Response, Liver Function and Immunological Indicators in Liver Cancer Patients With HBV Infection Undergoing PD-1 Inhibition Combinational Therapy;Frontiers in Immunology;2022-05-25

4. Risk of HBV reactivation during therapies for HCC: A systematic review;Hepatology;2021-12-16

5. Prediction of survival according to kinetic changes of cytokines and hepatitis status following radioembolization with yttrium-90 microspheres;Journal of the Formosan Medical Association;2021-04